MIDDLE EAST PHARMA AND CHEMICAL INDUSTRIES CO.-COMPANY INSIGHT - TF Market Research

MIDDLE EAST PHARMA AND CHEMICAL INDUSTRIES CO.-COMPANY INSIGHT

35 pages — Published Apr 23, 2010
Price $1,495.00  |  Buy this Report Now
  
This report is also available for purchase on a per-page basis.

About This Report

  
Brief Excerpt:
...Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co. [NonUS -- Symbol : Private] P.O. Box ####, Amman #####, Jordan email: main@midpharma.com Website: http://www.midpharma.com Phone: ###-#-####### Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co. (Midpharma) is engaged in contract manufacturing, marketing and sale of pharmaceutical solid dose preparation and chemical products. The company was founded in ####. Midpharma's product range includes: Antibiotics, analgesics-antipyretics, vitamins, haematinics, cardiovascular preparations, hypoglycemics, antiulcerants and antifungals. The company's products include: Hypodipine, Midopril, Lapril, Diamid, Glucana, Lansomid, Fungimid, Lipomid, Midofen, Nalgofen, Ferrovita, Vitamid, Alphapress, Vonta, Epokine, etc....
  
Source:
Author:
LSA
Company
MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES CO
Geographic Regions
ASIA , JORDAN , MIDDLE EAST
Non-Billable Page Numbers
3
Format:
PDF Adobe Acrobat
Sections
TitleStarting PageNumber of Pages
MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES & MEDICAL APPLIANCES CO.11
Private Company Report11
ABOUT Life Science Analytics21
Disclaimer21
Business Summary41
Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co. [NonUS -- Symbol : Private]41
Product Glance51
Products by Phase of Development Trial Phase51
No. of Products510
Products by Phase of Development Chart51
Products by Disease Hub Classification Disease Hub61
Products by Disease Hub Classification Chart61
Products by Indication Blood and Lymphatic System Indication71
Blood and Lymphatic System Chart71
Cardiovascular and Circulatory System Indication81
Cardiovascular and Circulatory System Chart81
Central Nervous System Indication91
Central Nervous System Chart91
Digestive System Indication101
Digestive System Chart101
Infections Indication111
Infections Chart111
Kidneys and Genito-Urinary System Indication121
Kidneys and Genito-Urinary System Chart121
Metabolic/Endocrinology Indication131
Metabolic/Endocrinology Chart131
Miscellaneous Indication141
Miscellaneous Chart141
Product Pipeline151
Products Condition Treated Trial Phase Source Partner151
Product Details161
1 . Epokine Active Ingredient Product Type Disease Hub Therapeutic Indication Current Trial Description161
Route of Administration Mechanism of Action Mode of Action161
erythropoietin (recombinant, human)161
Molecule Type Classification161
Prescription Route of Administration Mechanism of Action171
Mode of Action171
doxazosin mesylate171
Chemical Name176
Chemical Structure176
Molecular Weight Molecular Formula Molecule Type Classification173
Route of Administration Mechanism of Action Mode of Action Trial Details Last Updated171
4 . Fungimide Active Ingredient Product Type Disease Hub Therapeutic Indication Current Trial Description181
Route of Administration Mechanism of Action Mode of Action181
fluconazole181
Route of Administration Mechanism of Action191
Mode of Action192
simvastatin191
Prescription Route of Administration Mechanism of Action201
doxazosin mesylate201
Route of Administration Mechanism of Action Mode of Action203
amlodipine201
Molecular Weight Molecular Formula Molecule Type Classification212
enalapril211
captopril221
Trial Details Last Updated 10 . Ferrovita Active Ingredient221
Product Type Disease Hub Therapeutic Indication Current Trial Description231
Route of Administration Mechanism of Action241
Mode of Action241
ibuprofen241
Chemical Name Chemical Structure244
Chemical Name241
Chemical Structure251
Molecular Weight Molecular Formula Molecule Type Classification254
caffeine252
Route of Administration Mechanism of Action262
Mode of Action262
acetaminophen261
propyphenazone261
diclofenac sodium271
Route of Administration Mechanism of Action Mode of Action282
gliclazide281
Chemical Name283
Chemical Structure283
glyburide281
famotidine291
Molecular Weight291
Molecular Formula Molecule Type Classification301
Prescription Route of Administration Mechanism of Action Mode of Action301
lansoprazole301
Molecular Weight Molecular Formula Molecule Type Classification301
Trial Details Last Updated311
Clinical Trial Classification and Product Counts321
Product Counts : "Unique Products" vs. "Product Records"321
Partnered vs. Unpartnered Products321
Lifecycle Management:331
Territorial Variations in Trial Phase:331
Non-Approval Letters:331
Notes on Specific Trial Phases342

Table Of Contents

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

About the Author


Cite this Report

  
MLA:
TF Market Research. "MIDDLE EAST PHARMA AND CHEMICAL INDUSTRIES CO.-COMPANY INSIGHT" Apr 23, 2010. Alacra Store. May 25, 2013. <http://www.alacrastore.com/storecontent/markintel/LIFE_SCIENCE_ANALYTICS-50374005>
  
APA:
TF Market Research. (2010). MIDDLE EAST PHARMA AND CHEMICAL INDUSTRIES CO.-COMPANY INSIGHT Apr 23, 2010. New York, NY: Alacra Store. Retrieved May 25, 2013 from <http://www.alacrastore.com/storecontent/markintel/LIFE_SCIENCE_ANALYTICS-50374005>
  
$1,495.00
$  £  
Have a Question?
Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.
More Research
Search all our Market Research from one place.